Company / EPS (Basic)
Thermo Fisher Scientific EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$15.52
FY2025
5-year range
$9.24 / $19.62
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
#10 of 160
Health Care
What the data says
Among 160 Health Care companies, Thermo Fisher Scientific is in the top 6% for eps (basic). Declined from $19.62 to $15.52 over the past 2 years.
Based on SEC 10-K filings.
15.52 in FY2025 with a 5-year CAGR of +16.3%. Top quartile in the Health Care sector.
Declined from $19.62 to $15.52 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 160This company $15.52 Sector average $1.57
▼
+885.8% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 12.6% year-over-year.
- Ranks #10 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2016.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.52 | -12.6% |
| FY2024 | $17.75 | -9.5% |
| FY2023 | $19.62 | +21.9% |
| FY2022 | $16.09 | +74.1% |
| FY2021 | $9.24 | +26.4% |
| FY2020 | $7.31 | +29.6% |
| FY2019 | $5.64 | +10.2% |
| FY2018 | $5.12 | +3.2% |
| FY2017 | $4.96 | +4.2% |
| FY2016 | $4.76 | +34.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026